NeoCardial Technologies™, LLC, is an early-stage medical device company, founded to innovate and offer improved treatment options and results for underserved patients suffering from late stage heart failure.

NeoCardial’s first product for commercialization, the eHeart™, is a non-blood contact, direct compression, extra-ventricular circulatory support device. Implanted using a thoracotomy procedure, the eHeart™ provides immediate cardiac output assistance to a failing heart.

The eHeart™ minimizes the complications associated with  Ventricular Assist Devices including surgical complications and the complications caused by direct blood contact. eHeart™ reduces complications while providing a dynamic means of sustaining circulation and physiological parameters that current and prior products have been unable to deliver. Unique to the eHeart™ is an innovative approach to addressing these issues.

NeoCardial Technologies, LLC, is an early-stage medical device company, founded to innovate and offer improved treatment options and resultsfor  underserved patients suffering from late stage heart failure.

NeoCardial’s first product for commercialization, the eHeart,™  is a non-blood contact, direct compression, extra-ventricular circulatory support device. Implanted using a thoracotomy procedure, the eHeart™ provides immediate cardiac output assistance to a failing heart. 

The eHeart™ minimizes the complications associated with  Ventricular Assist Devices including surgical complications and the complications caused by direct blood contact. eHeart™ reduces complications while providing a dynamic means of sustaining circulation and physiological parameters that current and prior products have been unable to deliver. Unique to the eHeart™ is an innovative approach to addressing these issues.